American Cancer Society Awards $2M for Diverse Cancer Research
- This topic has 4 replies, 3 voices, and was last updated 11 years ago by
.
-
Posts
-
I think it is too Willow and we sure could do with a lot more research getting done! But we will get there!
Thanks, Gavin! This really is good news…big $ for ongoing research in figuring out the early stage process of CC (how normal bike duct cell becomes malignant) and the another study to improve palliative care, that one with a focus on communication.
Keep it coming, Gavin. This brings much needed hope and encouragement!Hoping that much will come from it Lainy! And as we know, early detection of CC is so important and it is good that part of this research is focusing on the early stages here. Fingers crossed!!
American Cancer Society Awards $2M for Diverse Cancer Research.
“Aram Hezel, M.D., associate professor of Hematology/Oncology and vice chief of the division of Hematology/Oncology at the James P. Wilmot Cancer Center at URMC, is the leader of the second four-year project.
He received $720,000 to use a recently developed mouse model as a tool to further investigate Intrahepatic Cholangiocarcinoma (IHCC), a primary cancer of the liver with poor outcomes. Using the model and samples of liver tumors from patients, Hezel’s research team is studying two important and poorly understood aspects of this disease:
1) The early stages of this cancer type, which they hope will lead to an early detection plan;
2) The energy and recycling pathways activated in IHCC tumors and other cancers, which could eventually lead to promising new treatments.”
http://www.urmc.rochester.edu/news/story/index.cfm?id=3867
- The forum ‘Websites’ is closed to new topics and replies.